DrugPatentWatch Database Preview
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
« Back to Dashboard
Ataciguat is an investigational drug.
There have been 4 clinical trials for Ataciguat. The most recent clinical trial was a Phase 2 trial, which was initiated on November 1st 2008.
The most common disease conditions in clinical trials are Constriction, Pathologic, Aortic Valve Stenosis, and Neuralgia. The leading clinical trial sponsors are Sanofi, National Institutes of Health (NIH), and Jordan D. Miller, Ph.D.
Recent Clinical Trials for Ataciguat
|A Study Evaluating the Effects of Ataciguat (HMR1766) on Aortic Valve Calcification||National Institutes of Health (NIH)||Phase 2|
|A Study Evaluating the Effects of Ataciguat (HMR1766) on Aortic Valve Calcification||Sanofi||Phase 2|
|A Study Evaluating the Effects of Ataciguat (HMR1766) on Aortic Valve Calcification||Mayo Clinic||Phase 2|